Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Compass Wealth Management LLC

Compass Wealth Management LLC lowered its position in Option Care Health, Inc. (NASDAQ:OPCH) by 21.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 152,478 shares of the company’s stock after selling 40,650 shares during the quarter. Compass Wealth Management LLC’s holdings in Option Care Health were worth $3,537,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Whalen Wealth Management Inc. purchased a new position in shares of Option Care Health during the 4th quarter valued at approximately $253,000. Avior Wealth Management LLC lifted its holdings in Option Care Health by 4.8% during the 4th quarter. Avior Wealth Management LLC now owns 25,466 shares of the company’s stock worth $591,000 after buying an additional 1,166 shares during the last quarter. Sheets Smith Wealth Management lifted its holdings in Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after acquiring an additional 550 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its stake in Option Care Health by 6.2% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 943,300 shares of the company’s stock worth $21,885,000 after buying an additional 54,830 shares during the last quarter. Finally, UMB Bank n.a. increased its position in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on OPCH shares. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Barrington Research lifted their price target on Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Finally, Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

Option Care Health Price Performance

OPCH stock opened at $30.33 on Friday. The firm has a 50-day moving average of $24.42 and a two-hundred day moving average of $27.82. The firm has a market capitalization of $5.16 billion, a PE ratio of 25.49, a P/E/G ratio of 2.11 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.